TNNT2 and coronary artery disorder: This finding supports the potential additive predictive value of SMs also in combination with a novel sensitive biomarker such as high-sensitive troponin T (hs-cTnT), currently regarded as a marker of not only myocardial injury in acute coronary syndrome but also of CAD severity in stable ischemic heart disease (53).